Salarius Pharmaceuticals, INC. (DCOY) — S-1/A Filings

S-1/A Filings (7)

• Salarius to Offer 1.96M Shares, Warrants for Decoy Merger — Oct 21, 2025 Risk: high
  Salarius Pharmaceuticals, Inc. (DCOY) filed an S-1/A on October 21, 2025, detailing a proposed offering of 1,960,784 shares of common stock, or pre-funded warra
• Salarius Seeks $6M to Seal Decoy Merger, Nasdaq Listing Hinges on Shareholder Vote — Sep 23, 2025 Risk: high
  Salarius Pharmaceuticals, Inc. (DCOY) is offering 1,518,027 shares of common stock, Series A Warrants, and Series B Warrants at an assumed combined public offer
• Salarius Pharma Updates S-1/A, Reports $5.5M Net Loss in 2024 — Aug 8, 2025 Risk: high
  Salarius Pharmaceuticals, Inc. (DCOY) filed an S-1/A on August 8, 2025, updating its business and financial information and responding to SEC comments. The comp
• Salarius Faces Mounting Losses, Seeks Fresh Capital Amid S-1/A Filing — Jul 31, 2025 Risk: high
  Salarius Pharmaceuticals, Inc. (DCOY) filed an S-1/A on July 31, 2025, updating its business and financial information and responding to SEC comments. The compa
• Salarius Narrows Losses to $16.7M, Extends Runway to Q3 2025 — Jun 16, 2025 Risk: high
  Salarius Pharmaceuticals, Inc. (DCOY) filed an S-1/A on June 16, 2025, updating its business and financial information. The company reported a net loss of $16.7
• Salarius Narrows Loss to $19.9M, Seeks Fresh Capital for Drug Trials — May 22, 2025 Risk: high
  Salarius Pharmaceuticals, Inc. (DCOY) filed an S-1/A on May 22, 2025, updating its business and financial information and responding to SEC comments. The compan
• Salarius Pharmaceuticals Files S-1/A Update — Apr 17, 2025 Risk: medium
  Salarius Pharmaceuticals, Inc. filed an S-1/A on April 17, 2025, to update its business and financial information and respond to SEC comments. The company, form

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX